Biotech News

Home Biotech News Page 22
- Advertisement -

APPLE

Allogene Therapeutics Announces Positive Non-Hodgkin Lymphoma Study Results

San Francisco-based Allogene Therapeutics (NASDAQ:ALLO) reported favorable results from its dose escalation phase 1 alpha study of ALLO-501, a potential treatment for patients with...

RECENT POSTS